Results of SIGNAL‐AD, a randomized, phase 1b/2 trial to evaluate safety and efficacy of targeting reactive astrocytes with pepinemab, SEMA4D blocking antibody, in people with mild Alzheimer’s dementia

Eric R Siemers, Elizabeth E Evans, Terrence L Fisher, Megan Boise, Amber Foster, John E Leonard, Vikas Mishra, Crystal L Mallow, Anton P Porsteinsson, Raymond Scott Turner, Wendy Bond, John Huffaker, Martin R Farlow, Lawrence S Honig, Elizabeth Sheldon, Ryan A Townley, Paul Winner, Jeffrey Norton, R · 2025

Read Results of SIGNAL‐AD, a randomized, phase 1b/2 trial to evaluate safety and efficacy of targeting reactive astrocytes with pepinemab, SEMA4D blocking antibody, in people with mild Alzheimer’s dementia by Eric R Siemers, Elizabeth E Evans, Terrence L Fisher, Megan Boise, Amber Foster, John E Leonard, Vikas Mishra, Crystal L Mallow, Anton P Porsteinsson, Raymond Scott Turner, Wendy Bond, John Huffaker, Martin R Farlow, Lawrence S Honig, Elizabeth Sheldon, Ryan A Townley, Paul Winner, Jeffrey Norton, R (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11714990.txt.

Description

Reactive astrocytes, support cells that turn harmful, may drive part of Alzheimer's disease. Eric Siemers and a large team of co-authors report a randomized trial of pepinemab, an antibody that blocks a signal called SEMA4D. That signal switches astrocytes into their reactive state. The trial, named SIGNAL-AD, enrolled people with mild Alzheimer's dementia and tested the drug's safety and effect.

Earlier work showed the signal rises on sick nerve cells as the disease advances. Blocking it in a past trial in Huntington's disease was well tolerated and slowed a scan measure of decline. The report gives the design and results of this phase 1b/2 test in Alzheimer's disease. It shows whether the same approach is safe enough and active enough to take further in this illness.

Catalog record

CREATOREric R Siemers, Elizabeth E Evans, Terrence L Fisher, Megan Boise, Amber Foster, John E Leonard, Vikas Mishra, Crystal L Mallow, Anton P Porsteinsson, Raymond Scott Turner, Wendy Bond, John Huffaker, Martin R Farlow, Lawrence S Honig, Elizabeth Sheldon, Ryan A Townley, Paul Winner, Jeffrey Norton, R
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE3 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11714990

Browse the full library · About the Tower of Babel